Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | IDO1 | P14902 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1466264 | 0.98 | CYP2C19 (0.65) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| Bromide SCHEMBL11187006 | 0.98 | CYP2C19 (0.65) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL6682623 | 0.88 | CYP2C19 (0.66) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL11556861 | 0.87 | TAAR1 (0.54) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| Succinic Acid SCHEMBL11863609 | 0.87 | CYP2C19 (0.73) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL10435945 | 0.86 | CYP2C19 (0.52) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| Hydrochloric Acid SCHEMBL11119737 | 0.85 | CYP2C19 (0.48) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| Fumaric Acid SCHEMBL11188931 | 0.85 | CYP2C19 (0.56) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| Fumaric Acid SCHEMBL11188926 | 0.85 | CYP2C19 (0.56) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 | |
| SCHEMBL3078147 | 0.85 | CYP2C19 (0.64) | CYP2C19CYP1A2CYP2D6CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 907 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773768-B1 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2018-08-22 | — | — | EP | claimed |
| EP-1773768-A4 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2008-08-06 | — | — | EP | claimed |
| EP-1773768-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| EP-1068239-A2 | ANTIOXIDANT PEPTIDES DERIVED FROM APOLIPOPROTEIN A-IV | UNIVERSITY OF CINCINNATI (US) | 2001-01-17 | — | — | EP | claimed |
| US-6004987-A | ANTIINFLAMMATORY AGENTS FOR MAMMALS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1999-12-21 | — | — | US | claimed |
| WO-1999050286-A2 | ANTIOXIDANT PEPTIDES DERIVED FROM APOLIPOPROTEIN A-IV | UNIVERSITY OF CINCINNATI (US) | 1999-10-07 | — | — | WO | claimed |
| EP-0304649-B1 | Salts of 6-piperidino-2,4-diaminopyrimidin-3-oxide and of derivatives of thiamorpholin-3-on-5-carboxylic acid, their cosmetical and medicinal use. | L'OREAL (FR) | 1991-03-20 | — | — | EP | claimed |
| EP-0304649-A1 | Salts of 6-piperidino-2,4-diaminopyrimidin-3-oxide and of derivatives of thiamorpholin-3-on-5-carboxylic acid, their cosmetical and medicinal use. | L'OREAL (FR) | 1989-03-01 | — | — | EP | claimed |
| US-4323553-A | Composition for strengthening and revitalizing brittle or damaged nails containing a salt of 2-benzylthio ethylamine | L'OREAL (FR) | 1982-04-06 | — | — | US | claimed |
| US-4288433-A | THIOETHER AND A XANTHINE DERIVATIVE | L'OREAL (FR) | 1981-09-08 | — | — | US | claimed |
| US-4035492-A | Oral treatment of seborrhea with cysteamine derivatives | L'OREAL (FR) | 1977-07-12 | — | — | US | claimed |
| US-4002671-A | REDUCE SEBUM SECRETION ON SCALP OR SKIN | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-01-11 | — | — | US | claimed |
| US-20250345303-A1 | THERAPEUTIC COMPOSITIONS | WINTERMUTE BIOMEDICAL INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12383524-B2 | Therapeutic compositions of undecylenic acid and arginine | WINTERMUTE BIOMEDICAL, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-20250241883-A1 | THERAPEUTIC METHODS USING DECANOIC ACID AND AMINO ACIDS | WINTERMUTE BIOMEDICAL, INC. | 2025-07-31 | — | — | US | disclosed |
| US-4035492-A | Oral treatment of seborrhea with cysteamine derivatives | L'OREAL (FR) | 1977-07-12 | — | — | US | disclosed |
| US-4002671-A | REDUCE SEBUM SECRETION ON SCALP OR SKIN | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-01-11 | — | — | US | disclosed |
| US-3976781-A | SULFUR CONTAINING AMINES | L'OREAL (FR) | 1976-08-24 | — | — | US | disclosed |
| US-3950542-A | Cysteamine derivatives for oral treatment of seborrhea | L'OREAL (FR) | 1976-04-13 | — | — | US | disclosed |